Gilead | PharmaShots

PharmaShots Weekly Snapshot (Jul 27- 31, 2020)

August 3, 2020August 3, 2020Tuba Khan

1. Oxford Biomedica Signs Three Year Clinical Supply Agreement with Axovant to Manufacture and Supply AXO-Lenti-PD for Parkinson’s Disease Published: Jul 31, 2020 | [Read More...]

Insights+ Exclusive: COVID-19 Healthcare News Monthly Updates – July 2020

July 31, 2020July 31, 2020Shiwani Sharma

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 [Read More...]

PharmaShots Weekly Snapshot (Jul 20- 24, 2020)

July 27, 2020August 3, 2020Tuba Khan

1. Gilead and Galapagos’ Jyseleca (filgotinib) Receive the CHMP’s Positive Opinion for Moderate to Severe Rheumatoid Arthritis Published: Jul 24, 2020 | Tags: Gilead, [Read More...]

Gilead and Galapagos’ Jyseleca (filgotinib) Receive the CHMP’s Positive Opinion for Moderate to Severe Rheumatoid Arthritis

July 24, 2020July 24, 2020Tuba Khan

Shots: The CHMP’s positive opinion is based on P-III FINCH and P-II DARWIN programs that included 4,544 RA patient-years of experience with filgotinib. [Read More...]

Gilead to Acquire Tizona’s Stake for $300M

Gilead to Acquire Tizona’s Stakes for $300M

July 22, 2020July 22, 2020Tuba Khan

Shots: Gilead invests $300M to obtain 49.9% equity interest in Tizona and receives an exclusive option to acquire remaining stakes of Tizona for [Read More...]

PharmaShots Weekly Snapshot (Jul 13- 17, 2020)

July 20, 2020July 27, 2020Tuba Khan

1. Eli Lilly Reports Results of Mirikizumab in P-III OASIS-2 Study to Treat Moderate to Severe Plaque Psoriasis Published: Jul 17, 2020 | Tags: [Read More...]

Kronos Bio to Acquire Gilead’s SYK Inhibitor Portfolio

July 17, 2020July 17, 2020Tuba Khan

Shots: Gilead to receive an up front in cash and convertible notes into Kronos equity, regulatory & commercial milestones along with royalties on [Read More...]

MHLW Expedites the Reviews of Gilead’s Remdesivir to Treat Patients with COVID-19 in Japan

Gilead’s Veklury (remdesivir) Receives the TGA’s Approval to Treat Adults and Adolescents with Severe COVID-19 Symptoms

July 13, 2020July 13, 2020Shiwani Sharma

Shots: The TGA authorization follows the recent data shared by EMA and Singapore Health Sciences Authority for remdesivir’s approval in EU, Singapore and, [Read More...]

Insights+ Exclusive: COVID-19 Healthcare News Monthly Updates – June 2020

June 30, 2020July 3, 2020Tuba Khan

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 [Read More...]

Gilead Unveils the Price of Remdesivir as $390 per Vial in Developed Countries

June 30, 2020June 30, 2020Tuba Khan

Shots: Gilead will price its COVID-19 treatment at $390/ vial in the US and other developed countries, with a 5days treatment course of [Read More...]